Earnings ·
Amgen Inc. has released its unaudited financial results for the fourth quarter and full year ended December 31, 2025
AMGNAmgen Inc
Amgen Inc. has released its unaudited financial results for the fourth quarter and full year ended December 31, 2025. The filing details the company's use of non-GAAP metrics, including EBITDA and free cash flow, to provide additional context regarding its operational performance and liquidity. This announcement is a primary driver for investors to evaluate the company's recent profitability and overall financial health.